Clinical Trial Update: Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study [Phase 2]

View source ↗

Summary

A Phase II study evaluating toripalimab in combination with surufatinib for locally advanced thyroid cancer is ongoing, with no stated status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• Surufatinib (Surufatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Fudan University | Conditions: Thyroid Cancer | Phase 2 | Status: UNKNOWN